Photodynamic therapy as an up-to-date medical technology for the treatment of vulgar acne

Cover Page


Cite item

Full Text

Abstract

Background. Acne occurs in at least 85 % of male and female teenagers, often lasts a long time, with relapses in the 3rd and 4th decades of life. Since 2000, the technology of photodynamic therapy (PDT) has been actively used in many countries. Over the past two years, numerous important studies on the effectiveness of PDT for the treatment of acne have been conducted.
Aim. To generalize most recent information on the effects of PDT and to show its applicability in clinical
practice.
Methods. The data search and analysis were carried out using the US National Library of Medicine (PubMed database) and E-library online resources. The study included original articles published over the past two years and devoted to or related to the use of PDT for the treatment of acne vulgaris.
Results. A total of 55 articles were discovered. A total of 9 clinical trials or descriptions of clinical cases meeting the criteria for analysis were selected. The investigated clinical studies used various and ambiguous, non-standardized approaches in terms of photosensitizer incubation periods, cumulative doses of the light source energy and the number of treatment sessions. An analysis of the publications revealed a trend to use shorter incubation periods and less active photosensitizers in order to reduce the risk of such adverse events as erythema, edema, hyperpigmentation and blistering.
Discussion and conclusions. PDT is an effective and promising medical technology for the treatment of acne. PDT can be used for mild and severe inflammatory and cystic acne in patients with various skin types and lesion localizations. This type of acne therapy is currently performed using various approaches. Further research is needed to develop optimal and standard procedures for implementing this relevant and clinically beneficial medical technology.

About the authors

D. A. Andreev

Research Institute for Healthcare Organization and Medical Management, Moscow Healthcare Department

Author for correspondence.
Email: begaafd@mail.ru
ORCID iD: 0000-0003-0745-9474

MD, Ph.D., Leading Researcher, Dermatovenerologist, Scientific and Clinical Department

tel.: +7 (495) 530-12-89; +7 (985) 724-05-10

Sharikopodshipnikovskaya str., 9, Moscow, 115088, Russian Federation

Russian Federation

A. A. Zavyalov

Research Institute for Healthcare Organization and Medical Management, Moscow Healthcare Department

Email: azav06@mail.ru

Dr. Sci. (Med.), Prof.; Oncologist; Head of Scientific and Clinical Department

tel.: +7 (495) 530-12-89

Sharikopodshipnikovskaya str., 9, Moscow, 115088, Russian Federation

Russian Federation

T. N. Ermolaeva

Research Institute for Healthcare Organization and Medical Management, Moscow Healthcare Department

Email: ermolaeva_mzmo@mail.ru
ORCID iD: 0000-0002-3615-0292

Head of the Department of Methodology and Performance of Healthcare Institutions in the “Oncology” Profile

tel.: +7 (495) 530-12-89

Sharikopodshipnikovskaya str., 9, Moscow, 115088, Russian Federation

Russian Federation

A. G. Fisun

Research Institute for Healthcare Organization and Medical Management, Moscow Healthcare Department

Email: PokatiloAnn@gmail.com
ORCID iD: 0000-0002-9840-3267
Researcher, Scientific and Clinical Department

Sharikopodshipnikovskaya str., 9, Moscow, 115088, Russian Federation

Russian Federation

K. I. Polyakova

Research Institute for Healthcare Organization and Medical Management, Moscow Healthcare Department

Email: kseniia.poliakova93@gmail.com
ORCID iD: 0000-0002-8462-2813
Researcher, Scientific and Clinical Department

Sharikopodshipnikovskaya str., 9, Moscow, 115088, Russian Federation

Russian Federation

V. A. Dubovtseva

Research Institute for Healthcare Organization and Medical Management, Moscow Healthcare Department

Email: dubowtsewa.victoria@yandex.ru
Researcher, Scientific and Clinical Department

Sharikopodshipnikovskaya str., 9, Moscow, 115088, Russian Federation

Russian Federation

T. E. Maksimova

Research Institute for Healthcare Organization and Medical Management, Moscow Healthcare Department

Email: maksimovatamarae@mail.ru
Researcher, Scientific and Clinical Department

Sharikopodshipnikovskaya str., 9, Moscow, 115088, Russian Federation

Russian Federation

References

  1. Кубанова А. А., Аравийская Е. Р., Соколовский Е. В., Дворова Е. К., Фадеева Е. И. Системное лечения тяжелых форм акне: опыт использования изотретиноина в Российской Федерации. Вестник дерматологии и венерологии. 2013;5:102–114.
  2. Zouboulis C. C., Katsambas A. D., Kligman A. M. Pathogenesis and treatment of acne and rosacea. Berlin, Heidelberg: Springer-Verlag, 2014.
  3. Бронфман С. А., Шерина Т. Ф., Иванова Л. П., Кудаева Л. М. Угревая болезнь: современные представления о патогенезе и возможности комплексной коррекции аллопатическими и нелекарственными методами. Вестник новых медицинских технологий. 2016;1:235–240.
  4. Масюкова С. А., Ахтямов С. Н. Акне: проблема и решение. Consilium Medicum. Дерматология. 2002;4(5):217–224.
  5. De Federatie Medisch Specialisten. Acne. Nederlandse Vereniging voor Dermatologie en Venerologie. De richtlijn. 2014. https://www.demedischspecialist.nl/ (toegankelijk op 01.11.19). [The Federation of Medical Specialists. Acne. Dutch Association for Dermatology and Venerology. The Guidelines. 2014. https://www.demedischspecialist.nl/ (accessed 01.11.2019). (In Dutch)].
  6. Колодий А. А., Шатохина Е. А., Халилуллин Р. И. Обзор современных физиотерапевтических методов лечения акне. Медицинский алфавит. 2019;1(7):15–18.
  7. Donnarumma M., Fattore D., Greco V., Ferrillo M., Vastarella M., Chiodini P., et al. How to Increase Adherence and Compliance in Acne Treatment? A Combined Strategy of SMS and Visual Instruction Leaflet. Dermatology. 2019:1–8. doi: 10.1159/000502575
  8. Zheng Y., Yu E., Weng Q., Zhou L., Li Q. Optimization of hydrogel containing toluidine blue O for photodynamic therapy in treating acne. Lasers Med Sci. 2019;34(8):1535–1545. doi: 10.1007/s10103-019-02727-2
  9. Vallerand I. A., Lewinson R. T., Farris M. S., Sibley C. D., Ramien M. L., Bulloch A. G. M. et al. Efficacy and adverse events of oral isotretinoin for acne: a systematic review. Br J Dermatol. 2018;178(1):76–85. doi: 10.1111/bjd.15668
  10. Ахтямов С. Н. Междисциплинарный симпоузиум «Новое в дерматологии и косметологии, гинекологии, андрологии». Инновационные возможности флуоресцентной диагностики и фотодинамической терапии с препаратами аласенс и фотосенс в дерматологии, косметологии и гинекологии. Эффективная фармакотерапия. 2013;25:44–50.
  11. Hongcharu W., Taylor C. R., Chang Y., Aghassi D., Suthamjariya K., Anderson R. R. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115(2):183–192. doi: 10.1046/j.1523-1747.2000.00046.x
  12. Владимиров В. В., Олисова О. Ю., Вертиева Е. Ю., Горячкина М. В., Смирнов К. В. Фотодинамическая терапия при лечении вульгарных угрей. Российский журнал кожных и венерических болезней. 2014;5:54–58.
  13. Divaris D. X., Kennedy J. C., Pottier R. H. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol. 1990;136(4):891–897.
  14. Ozog D. M., Rkein A. M., Fabi S. G., Gold M. H., Goldman M. P., Lowe N. J. et al. Photodynamic Therapy: A Clinical Consensus Guide. Dermatol Surg. 2016;42(7):804–827. doi: 10.1097/DSS.0000000000000800
  15. Ibbotson S. H. An overview of topical photodynamic therapy in dermatology. Photodiagnosis Photodyn Ther. 2010;7(1):16–23. doi: 10.1016/j.pdpdt.2009.12.001
  16. Boen M., Brownell J., Patel P., Tsoukas M. M. The Role of Photodynamic Therapy in Acne: An Evidence-Based Review. Am J Clin Dermatol. 2017;18(3):311–321. doi: 10.1007/s40257-017-0255-3
  17. Zhang J., Zhang X., He Y., Wu X., Huang J., Huang H. et al. Photodynamic therapy for severe facial acne vulgaris with 5 % 5-aminolevulinic acid vs 10 % 5-aminolevulinic acid: A split-face randomized controlled study. J Cosmet Dermatol. 2019, Jun 12. doi: 10.1111/jocd.13038 [Epub ahead of print]
  18. Warren C. B., Karai L. J., Vidimos A., Maytin E. V. Pain associated with aminolevulinic acid-photodynamic therapy of skin disease. J Am Acad Dermatol. 2009;61(6):1033–1043. doi: 10.1016/j.jaad.2009.03.048
  19. Wiegell S. R., Skiveren J., Philipsen P. A., Wulf H. C. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol. 2008;158(4):727–733. doi: 10.1111/j.1365-2133.2008.08451.x
  20. Cottrell W. J., Paquette A. D., Keymel K. R., Foster T. H., Oseroff A. R. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res. 2008;14(14):4475–4483. doi: 10.1158/1078-0432.CCR-07-5199
  21. Christiansen K., Bjerring P., Troilius A. 5-ALA for photodynamic photorejuvenation — optimization of treatment regime based on normal-skin fluorescence measurements. Lasers Surg Med. 2007;39(4):302–310. doi: 10.1002/lsm.20488
  22. Serini S. M., Cannizzaro M. V., Dattola A., Garofalo V., Del Duca E., Ventura A. et al. The efficacy and tolerability of 5-aminolevulinic acid 5 % thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study. J Cosmet Dermatol. 2019;18(1):156–162. doi: 10.1111/jocd.12670
  23. Doshi A., Zaheer A., Stiller M. J. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997;36(6):416–418. doi: 10.1046/j.1365-4362.1997.00099.x
  24. Sakamoto F. H., Lopes J. D., Anderson R. R. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part I. Acne vulgaris: when and why consider photodynamic therapy? J Am Acad Dermatol. 2010;63(2):183–193; quiz 93–94. doi: 10.1016/j.jaad.2009.09.056
  25. Nicklas C., Rubio R., Cardenas C., Hasson A. Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-A simple, blind, randomized, and controlled trial. Photodermatol Photoimmunol Photomed. 2019;35(1):3–10. doi: 10.1111/phpp.12413
  26. Choi M. S., Yun S. J., Beom H. J., Park H. R., Lee J. B. Comparative study of the bactericidal effects of 5-aminolevulinic acid with blue and red light on Propionibacterium acnes. J Dermatol. 2011;38(7):661–666. doi: 10.1111/j.1346-8138.2010.01094.x
  27. Giuliani J., Marzola M. The management of skin toxicity during erlotinib in advanced non-small cell lung cancer: how much does it cost? Cutan Ocul Toxicol. 2013;32(3):248–251. doi: 10.3109/15569527.2013.765444
  28. Austin E., Jagdeo J. An In Vitro Approach to Photodynamic Therapy. J Vis Exp. 2018;138. doi: 10.3791/58190
  29. Moftah N. H., Ibrahim S. M., Wahba N. H. Intense pulsed light versus photodynamic therapy using liposomal methylene blue gel for the treatment of truncal acne vulgaris: a comparative randomized split body study. Arch Dermatol Res. 2016;308(4):263–268. doi: 10.1007/s00403-016-1639-6
  30. Fadel M., Salah M., Samy N., Mona S. Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris. J Drugs Dermatol. 2009;8(11):983–990.
  31. Kim J. E., Hwang J. I., Lee J. I., Cho B. K., Park H. J. Pilot study on photodynamic therapy for acne using chlorophyll: evaluator-blinded, split-face study. J Dermatolog Treat. 2012;23(1):35–36. doi: 10.3109/09546634.2010.514598
  32. Choi S. H., Seo J. W., Kim K. H. Comparative study of the bactericidal effects of indocyanine green- and methyl aminolevulinate-based photodynamic therapy on Propionibacterium acnes as a new treatment for acne. J Dermatol. 2018;45(7):824–829. doi: 10.1111/1346-8138.14347
  33. Wanitphakdeedecha R., Tavechodperathum N., Tantrapornpong P., Suphatsathienkul P., Techapichetvanich T., Eimpunth S. et al. Acne treatment efficacy of intense pulsed light photodynamic therapy with topical licochalcone A, l-carnitine, and decanediol: A spilt-face, double-blind, randomized controlled trial. J Cosmet Dermatol. 2019, Oct 6. doi: 10.1111/jocd.13178 [Epub ahead of print]
  34. Kolbe L., Immeyer J., Batzer J., Wensorra U., tom Dieck K., Mundt C. et al. Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res. 2006;298(1):23–30. doi: 10.1007/s00403-006-0654-4
  35. Weber T. M., Ceilley R. I., Buerger A., Kolbe L., Trookman N. S., Rizer R. L. et al. Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A. J Cosmet Dermatol. 2006;5(3):227–232. doi: 10.1111/j.1473-2165.2006.00261.x
  36. Udompataikul M., Srisatwaja W. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study. J Eur Acad Dermatol Venereol. 2011;25(6):660–665. doi: 10.1111/j.1468-3083.2010.03845.x
  37. Del Duca E., Manfredini M., Petrini N., Farnetani F., Chester J., Bennardo L. et al. Daylight Photodynamic Therapy with 5-aminolevulinic acid 5 % gel for the treatment of mild-to-moderate inflammatory acne. G Ital Dermatol Venereol. 2019, Sep 12. doi: 10.23736/S0392-0488.19.06392-2 [Epub ahead of print]
  38. Zheng Z., Zhang L. L., Shi L., Zhang Y. F., Wang B., Wu Q. Q. et al. What is the most relevent factor causing pain during ALA-PDT? A multicenter, open clinical pain score research trial of actinic keratosis, acne and condylomata acuminata. Photodiagnosis Photodyn Ther. 2019;26:73–78. doi: 10.1016/j.pdpdt.2019.03.001
  39. Zhang L., Wu Y., Zhang Y., Liu X., Wang B., Wang P. et al. Topical 5-aminolevulinic photodynamic therapy with red light vs intense pulsed light for the treatment of acne vulgaris: A spilit face, randomized, prospective study. Dermatoendocrinol. 2017;9(1):e1375634. doi: 10.1080/19381980.2017.1375634
  40. Qureshi S., Lin J. Y. Utilizing non-ablative fractional photothermolysis prior to ALA-photodynamic therapy in the treatment of acne vulgaris: a case series. Lasers Med Sci. 2017;32(3):729–732. doi: 10.1007/s10103-016-2029-1
  41. Kennedy J. C., Pottier R. H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14(4):275–292. doi: 10.1016/1011-1344(92)85108-7
  42. Stolik S., Tomas S. A., Ramon-Gallegos E., Sanchez F. Kinetic study of delta-Ala induced porphyrins in mice using photoacoustic and fluorescence spectroscopies. J Photochem Photobiol B. 2002;68(2–3):117–122. doi: 10.1016/s1011-1344(02)00381-0
  43. Orringer J. S., Sachs D. L., Bailey E., Kang S., Hamilton T., Voorhees J. J. Photodynamic therapy for acne vulgaris: a randomized, controlled, split-face clinical trial of topical aminolevulinic acid and pulsed dye laser therapy. J Cosmet Dermatol. 2010;9(1):28–34. doi: 10.1111/j.1473-2165.2010.00483.x
  44. Oh S. H., Ryu D. J., Han E. C., Lee K. H., Lee J. H. A comparative study of topical 5-aminolevulinic acid incubation times in photodynamic therapy with intense pulsed light for the treatment of inflammatory acne. Dermatol Surg. 2009;35(12):1918–1926. doi: 10.1111/j.1524-4725.2009.01315.x
  45. Dessinioti C., Masouri S., Drakaki E., Katsambas A., Antoniou C. Short-contact, low-dose methyl aminolaevulinate photodynamic therapy for acne vulgaris. Br J Dermatol. 2016;175(1):215. doi: 10.1111/bjd.14460
  46. Sakamoto F. H., Torezan L., Anderson R. R. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy. J Am Acad Dermatol. 2010;63(2):195–211; quiz-2. doi: 10.1016/j.jaad.2009.09.057
  47. Riddle C. C., Terrell S. N., Menser M. B., Aires D. J., Schweiger E. S. A review of photodynamic therapy (PDT) for the treatment of acne vulgaris. J Drugs Dermatol. 2009;8(11):1010–1019.
  48. Kwon H. H., Moon K. R., Park S. Y., Yoon J. Y., Suh D. H., Lee J. B. Daylight photodynamic therapy with 1.5 % 3-butenyl 5-aminolevulinate gel as a convenient, effective and safe therapy in acne treatment: A double-blind randomized controlled trial. J Dermatol. 2016;43(5):515–521. doi: 10.1111/1346-8138.13191
  49. Tyrrell J., Campbell S. M., Curnow A. The effect of air cooling pain relief on protoporphyrin IX photobleaching and clinical efficacy during dermatological photodynamic therapy. J Photochem Photobiol B. 2011;103(1):1–7. doi: 10.1016/j.jphotobiol.2010.12.011

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Andreev D.A., Zavyalov A.A., Ermolaeva T.N., Fisun A.G., Polyakova K.I., Dubovtseva V.A., Maksimova T.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies